Literature DB >> 21146527

The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys.

Timothy P Gilmour1, Christopher A Lieu, Mark J Nolt, Brigitte Piallat, Milind Deogaonkar, Thyagarajan Subramanian.   

Abstract

Dopamine replacement therapy with levodopa (LD) is currently the most effective pharmacological treatment for Parkinson's disease (PD), a neurodegenerative disorder characterized by dysfunction of basal ganglia electrophysiology. The effects of chronic LD treatments on the electrophysiological activity of the subthalamic nucleus (STN) and the substantia nigra reticulata (SNR) in parkinsonism are not clear. In the present study we examined the effects of chronic LD treatments on the firing rate and firing pattern of STN and SNR neurons in the stable hemiparkinsonian monkey model of PD. We also evaluated local field potentials of both nuclei before and after LD treatments. In a stable hemiparkinsonian state, STN and SNR had a mean firing rate of 42.6 ± 3.5H z (mean ± SEM) and 52.1 ± 5.7 Hz, respectively. Chronic intermittent LD exposure induced marked amelioration of parkinsonism with no apparent drug-induced motor complications. LD treatments did not significantly change the mean firing rate of STN neurons (41.3 ± 3.3 Hz) or bursting neuronal firing patterns. However, LD treatments induced a significant reduction of the mean firing rates of SNR neurons to 36.2 ± 3.3 Hz (p<0.05) and a trend toward increased burstiness. The entropy of the spike sequences from STN and SNR was unchanged by LD treatment, while there was a shift of spectral power into higher frequency bands in the LFPs. The inability of chronic LD treatments to reduce the bursty firing patterns in the STN and SNR should be further examined as a potential pathophysiological mechanism for PD symptoms that are refractory to LD treatments.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146527      PMCID: PMC3040249          DOI: 10.1016/j.expneurol.2010.12.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  50 in total

1.  Approximate entropy as a measure of system complexity.

Authors:  S M Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor.

Authors:  R Levy; W D Hutchison; A M Lozano; J O Dostrovsky
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  Nonlinear analysis of discharge patterns in monkey basal ganglia.

Authors:  Olivier Darbin; Jesus Soares; Thomas Wichmann
Journal:  Brain Res       Date:  2006-09-20       Impact factor: 3.252

4.  Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.

Authors:  Andrea A Kühn; Andreas Kupsch; Gerd-Helge Schneider; Peter Brown
Journal:  Eur J Neurosci       Date:  2006-04       Impact factor: 3.386

5.  Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease.

Authors:  P Brown; A Oliviero; P Mazzone; A Insola; P Tonali; V Di Lazzaro
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 6.  Oscillations in the basal ganglia under normal conditions and in movement disorders.

Authors:  Plamen Gatev; Olivier Darbin; Thomas Wichmann
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

7.  Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound.

Authors:  Thyagarajan Subramanian; Christopher A Lieu; Kumaraswamy Guttalu; Daniela Berg
Journal:  Ultrasound Med Biol       Date:  2010-03-07       Impact factor: 2.998

8.  Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients.

Authors:  M Magnin; A Morel; D Jeanmonod
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

9.  Effects of apomorphine on globus pallidus neurons in parkinsonian patients.

Authors:  W D Hutchinson; R Levy; J O Dostrovsky; A M Lozano; A E Lang
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

10.  Identification of the subthalamic nucleus in deep brain stimulation surgery with a novel wavelet-derived measure of neural background activity.

Authors:  André Snellings; Oren Sagher; David J Anderson; J Wayne Aldridge
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

View more
  10 in total

Review 1.  The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.

Authors:  Christopher A Lieu; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2011-09-24       Impact factor: 4.077

2.  The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.

Authors:  Timothy P Gilmour; Brigitte Piallat; Christopher A Lieu; Kala Venkiteswaran; Renuka Ramachandra; Anand N Rao; Andrew C Petticoffer; Matthew A Berk; Thyagarajan Subramanian
Journal:  Brain       Date:  2011-09-12       Impact factor: 13.501

3.  Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia.

Authors:  Martin Tamtè; Ivani Brys; Ulrike Richter; Nedjeljka Ivica; Pär Halje; Per Petersson
Journal:  J Neurophysiol       Date:  2016-01-06       Impact factor: 2.714

4.  Abnormal Bursting as a Pathophysiological Mechanism in Parkinson's Disease.

Authors:  Cj Lobb
Journal:  Basal Ganglia       Date:  2014-04-01

5.  Transplantation of human retinal pigment epithelial cells in the nucleus accumbens of cocaine self-administering rats provides protection from seeking.

Authors:  Kala Venkiteswaran; Danielle N Alexander; Matthew D Puhl; Anand Rao; Amanda L Piquet; Jennifer E Nyland; Megha P Subramanian; Puja Iyer; Matthew M Boisvert; Erin Handly; Thyagarajan Subramanian; Patricia Sue Grigson
Journal:  Brain Res Bull       Date:  2015-11-10       Impact factor: 4.077

Review 6.  Review: electrophysiology of basal ganglia and cortex in models of Parkinson disease.

Authors:  Damien J Ellens; Daniel K Leventhal
Journal:  J Parkinsons Dis       Date:  2013-01-01       Impact factor: 5.568

7.  The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate.

Authors:  Christopher A Lieu; Kala Venkiteswaran; Timothy P Gilmour; Anand N Rao; Andrew C Petticoffer; Erin V Gilbert; Milind Deogaonkar; Bala V Manyam; Thyagarajan Subramanian
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-10       Impact factor: 2.629

8.  Reduced information transmission in the internal segment of the globus pallidus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced rhesus monkey models of Parkinson's disease.

Authors:  Yan He; Jue Wang; Guodong Gao; Guangjun Zhang
Journal:  Neural Regen Res       Date:  2012-09-15       Impact factor: 5.135

Review 9.  An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.

Authors:  Andrea Terron; Anna Bal-Price; Alicia Paini; Florianne Monnet-Tschudi; Susanne Hougaard Bennekou; Marcel Leist; Stefan Schildknecht
Journal:  Arch Toxicol       Date:  2017-12-05       Impact factor: 5.153

10.  The role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned rats.

Authors:  Asier Aristieta; Garikoitz Azkona; Ainhoa Sagarduy; Cristina Miguelez; José Ángel Ruiz-Ortega; Rosario Sanchez-Pernaute; Luisa Ugedo
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.